HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

glycinol

a phytoestrogen and precursor to glyceollin; isolated from Glycine max; structure in first source

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Flavonols: 321
        glycinol: 3
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Flavonols: 321
        glycinol: 3

Experts

1.	Boue, Stephen M: 1 article (01/2017)
2.	Bunnell, Bruce A: 1 article (01/2017)
3.	Burow, Matthew E: 1 article (01/2017)
4.	Glowacki, Julie: 1 article (01/2017)
5.	Jones, Robert B: 1 article (01/2017)
6.	Strong, Amy L: 1 article (01/2017)
7.	Balboni, Gianfranco: 1 article (07/2007)
8.	Bazzy-Asaad, Alia: 1 article (07/2007)
9.	Chao, Dongman: 1 article (07/2007)
10.	Xia, Ying: 1 article (07/2007)

Related Diseases

1.	Osteoporosis 01/01/2017 - "The results from these studies support investigating glycinol as a potential preventive or treatment for osteoporosis." 01/01/2017 - "Phytoestrogens, such as glycinol, have recently gained significant attention as an alternative therapy for osteoporosis due to their structural similarity to estradiol and their bone-generating potential. "
2.	Lordosis 08/01/2001 - "Infusions of selective MOR agonists, H-Tyr-d-Ala-Gly-N-Met-Phe-glycinol-enkephalin (DAMGO) or endomorphin-1, into the medial preoptic nucleus attenuated lordosis, and their effects were blocked with the MOR antagonist H-d-Phe-Cys-Tyr-d-Trp-Orn-Thr-Pen-Thr-NH(2) (CTOP). "
3.	Hypoxia (Hypoxemia) 07/01/2007 - "The main findings are that (1) similar to DADLE (10 microM), H-Dmt-Tic-NH-CH (CH(2)--COOH)-Bid (1-10 microM), a more specific and potent DOR agonist significantly attenuated anoxic K(+) derangement in cortical slice; (2) [D-Ala(2), N-Me-Phe(4), glycinol(5)]-enkephalin (DAGO; 10 microM), a MOR agonist, did not produce any appreciable change in anoxic disruption of K(+) homeostasis; (3) absence of Ca(2+) greatly attenuated anoxic K(+) derangement; (4) inhibition of Ca(2+)-activated K(+) (BK) channels with paxilline (10 microM) reduced anoxic K(+) derangement; (5) DADLE (10 microM) could not further reduce anoxic K(+) derangement in the Ca(2+)-free perfused slices or in the presence of paxilline; and (6) glybenclamide (20 microM), a K(ATP) channel blocker, decreased anoxia-induced K(+) derangement, but DADLE (10 microM) could further attenuate anoxic K(+) derangement in the glybenclamide-perfused slices. "

Related Drugs and Biologics

1.	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)
2.	Enkephalins
3.	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)
4.	Phytoestrogens (Phytoestrogen)
5.	Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)
6.	Glyburide (Glibenclamide)
7.	Estradiol (Delestrogen)
8.	Adenosine Triphosphate (ATP)
9.	2',6'- dimethyltyrosyl- 1,2,3,4- tetrahydroisoquinoline- 3- carboxylic acid
10.	endomorphin 1

Related Therapies and Procedures

1.	Therapeutics